A lthough retinoblastoma is relatively uncommon, it can have devastating consequences for the children affected by it. If treated too late, it can lead to the loss of the eye, invasion of the brain and death.
Retinoblastoma does not affect everyone equally. In high-income countries, fewer than 5% of children die as a result of the condition, thanks to early diagnosis and specialist treatment. In Africa, however, it is typical to see 70% of children with retinoblastoma die, mainly because they presented too late. When mothers do present at a tertiary centre with a child who has advanced retinoblastoma, they often report that they have had several interactions with different health professionals over many months or even years, but did not get the referral or care they needed. Every health professional reading this issue of the Community Eye Health Journal has a chance to redress this balance. We need to find and treat children with retinoblastoma early, before it causes disfigurement or death.
Doing so successfully requires adopting a multidisciplinary, multi-level and internationally collaborative approach that looks at the health system as a whole (see Table 1 counselling and high quality treatment (including good prosthetics) are all needed to increase the uptake of services and save lives.
Ministry of health
Ministries of health have the power to made dramatic improvements to the early detection and treatment of retinoblastoma. They can:
• Create public health campaigns to raise awareness that 'seeing something white' inside a child's eye is a medical emergency
• Include basic ocular history taking and eye examination techniques in the curriculum of community nurses
• Off er subsidised access to specialist treatment for children with this life-threatening condition.
Parents must be made aware that they should seek help urgently if they see something white inside their child's eyes. Emphasise that parents should not let their child be turned away and must not take 'no' for an answer if they feel there is something wrong.
A worthwhile investment
Investing resources in the early detection and referral of children with retinoblastoma has wider benefi ts in the fi elds of childhood blindness in low-and middle-income countries, as the same criteria (something white in the eye) will also help with the early detection of childhood cataract. Late presentation of childhood cataract is the leading cause of treatable blindness in children, and is entirely preventable if cataracts are detected and treated in time.
In the community
Nurses and health workers seeing children in the community can check children's eyes during routine immunisation appointments, for example. Something abnormal, white or shiny, or a squint, may be the fi rst sign of retinoblastoma and requires urgent specialist referral. Listen to VOLUME 31 • NUMBER 101 • 2018
About this issue
Retinoblastoma is a rare condition with devastating consequences. If left untreated, it can lead to loss of the eye, invasion of the brain and death. In this issue, we off er information and guidance about the detection, diagnosis and treatment of retinoblastoma, including advice about screening for family members when genetic testing is not available, and a step-by-step guide to enucleation. We hope that every health professional reading this journal will raise awareness of this condition so that -globally -we have a better chance to save the life, eyes and sight of children with retinoblastoma.
Please support us
We rely on donations / subscriptions from charities and generous individuals to carry out our work. We need your help. In Tanzania, community nurses have been trained to examine the red refl ex (p. 23) using an Arclight ophthalmoscope. The Arclight is an aff ordable, solarpowered and easy-to-use ophthalmoscope. It has shown preliminary promise; the community nurses found it easy to learn and began picking up cases of cataract and retinoblastoma by using it. Nurses can learn how to examine the red refl ex at the same time as examining the child's other systems.
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Tertiary centres
At tertiary centres, histopathologists have a crucial role: once the eye is removed the child may be able to leave hospital completely cured or may need chemotherapy 
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International collaboration
To promote this multi-level, multi-disciplinary and internationally collaborative approach, the Commonwealth Eye Health Consortium has provided start-up funding for an Rb-Network known as Rb-NET, which has already generated specifi c country plans, a set of core outcome indicators, best practice protocols and a practical resource manual (http://cehc.lshtm.ac.uk/dr-links/rbnet/).
Basic clinical research questions still need to be answered. For instance, researchers in Uganda have shown an improvement in survival by giving chemotherapy before surgery on the basis that so many children have extra-ocular spread at time of presentation. On the other hand, a small study from Tanzania showed that 60% of children for whom there was good histology after enucleation had complete excision of the tumour with low risk and never needed chemotherapy. So which should come fi rst in these settings -chemotherapy or surgery? By combining multi-centre and multi-country clinical research, as Rb-NET has started to do, we can begin to answer these questions and prevent needless tragedies.
This issue of the Journal demonstrates that there is real momentum and determination to improve outcomes for children with Rb in all countries across the world. It contains concise, practical information that should help all of us to make a diff erence. 
Specialist eye centre
Seek help urgently if you see something white inside the centre of the eye (the pupil) OR if you take a photograph and only one eye has a red dot in the centre Do not let anyone turn you away and do not take no for an answer until a doctor at a hospital has examined the child's eyes using a bright light
Believe the parents if they say they have seen something white inside the pupil and seek specialist advice. A child with retinoblastoma is not a medical specimen. They are a complete individual with thoughts, feelings, hopes, dreams, likes and dislikes. They have the ability to generate every kind of emotion in those who care for them. They are desperately loved, and most parents would give their own eye if it could spare their child's suff ering.
In evaluating diff erent treatments, we must weigh the value of each treatment in relation to the child's complete wellbeing. We must look beyond the physical body to embrace and care for the child's emotional health, during therapy and long after into adulthood.
Perhaps if we collectively take care to consider 'children', 'families' and 'survivors' rather than 'cases', we will together establish a level ground on which we can both treat the cancer, and heal the spirit in equal measure to set the child up for a healthy, happy future.
